Ken Rosen
I am a medical research doctor with extensive experience in studying both the development of skeletal muscle and the nervous system and some of the disorders that compromise them. My professional interests are not limited to biomedical research but also in training and educating new scientists. A native New Englander, I relish the history of this region of the US and am a fan of many of its institutions and traditions.
Read More »
...
- Page Views
- 1,005
- Content
- 6
- Fans
- 0
- Contributor since
- 1/2/2011
Interests
biological sciences, medicine, diseases and disorders, scientific methods and techniques, sports, new englandFavorites
None yet.Fans
None yet.
Displaying Results 1 - 6 (of 6) for All Content
-
Study Shows Increase in Use of Antibiotics of Last ResortAn analysis of medication records at Veteran's Administration hospitals showed a significant increase in the utilization of last line of defense antibiotics to fight bacterial infections. -
New Treatment Approved for Late-Stage MelanomaThe US Food and Drug Administration (FDA) announced the approval of an immune-modulating treatment that extends survival in patients with metastatic melanoma.
-
Implantable Device Detects Signs of Heart Attack in the BloodResearchers have developed an implantable, MRI-detectable, biomarker sensor that can measure the levels of blood serum markers of heart muscle damage. -
Surviving a Gunshot Wound to the BrainGiven the inherent tragedy of being shot, many things have to go right for a person to survive a bullet wound to the head. Extremely good fortune and the path of the bullet are critical to the outcome. -
Cultured Stem Cells Show Genetic ChangesA newly released study finds that cultures of human stem cells show significant changes in the makeup of their cellular DNA once they are cultured in a dish. This has important ramifications for future usage of stem cells in disease treatments.
-
Agreement Reached to Develop Advanced Blood Test to Detect Cancer CellsScientists at Massachusetts General Hospital partner with Johnson & Johnson to enhance the development of an improved method for finding and isolating cancer cells in the bloodstream.